Prestige Consumer Healthcare Inc 2024 Q3 Results Earnings Call Prestige Consumer Healthcare (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report Get prepared with the key expectations The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations
Annual Reports Prestige Consumer Healthcare Inc Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America View Prestige Consumer Healthcare Inc (PBH) current and estimated P/E ratio data provided by Seeking Alpha Earnings, and Cash Flow Outlook TARRYTOWN, NY, Aug 08, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc (NYSE:PBH) today reported financial results for its first quarter ended June 30 Prestige Consumer Healthcare (PBH) reported $26714 million in revenue year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations
Prestige Consumer Healthcare Pbh Earnings Date And Reports 2024 Earnings, and Cash Flow Outlook TARRYTOWN, NY, Aug 08, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc (NYSE:PBH) today reported financial results for its first quarter ended June 30 Prestige Consumer Healthcare (PBH) reported $26714 million in revenue year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations Narrow-moat Prestige Consumer Healthcare reported tepid first quarter earnings, starting fiscal 2025 on soft footing Total sales of $267 million were down 44% year over year as the North America Prestige Consumer Healthcare Inc PBH recorded first-quarter fiscal 2025 adjusted earnings per share (EPS) of 90 cents, which surpassed the Zacks Consensus Estimate by 47% However, the bottom
Comments are closed.